Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
43.18
+2.05 (4.98%)
At close: Mar 5, 2026

Shukra Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
18,9089,5683,5755149570
Market Cap Growth
100.70%167.65%595.01%443.89%35.73%-4.81%
Enterprise Value
18,8129,4153,504520199165
Last Close Price
43.1821.848.031.150.310.23
PE Ratio
108.8999.9219.2811.6712.6037.04
PS Ratio
29.2829.364.790.870.460.62
PB Ratio
28.7315.236.202.030.580.45
P/TBV Ratio
28.7315.236.202.030.580.45
P/FCF Ratio
-184.87--1.47-
P/OCF Ratio
-120.83-16.231.1812.97
EV/Sales Ratio
29.1328.894.700.880.971.47
EV/EBITDA Ratio
47.8460.9116.188.016.789.38
EV/EBIT Ratio
52.8475.6117.8711.1715.6358.82
EV/FCF Ratio
-181.91--3.09-
Debt / Equity Ratio
0.060.070.060.200.210.63
Debt / EBITDA Ratio
0.100.270.150.781.155.57
Debt / FCF Ratio
-0.81--0.52-
Net Debt / Equity Ratio
-0.15-0.13-0.120.040.190.59
Net Debt / EBITDA Ratio
-0.24-0.51-0.310.171.055.29
Net Debt / FCF Ratio
--1.530.98-0.840.48-7.39
Asset Turnover
-0.400.981.080.580.32
Inventory Turnover
-1.3516.2812.783.731.81
Quick Ratio
-2.332.891.000.621.46
Current Ratio
-3.793.971.251.282.28
Return on Equity (ROE)
-15.90%44.70%21.16%4.70%1.21%
Return on Assets (ROA)
-9.46%16.04%5.29%2.25%0.51%
Return on Invested Capital (ROIC)
51.34%16.91%47.35%20.16%4.24%1.16%
Return on Capital Employed (ROCE)
-17.90%30.80%14.40%5.60%1.00%
Earnings Yield
1.54%1.00%5.19%8.57%7.94%2.70%
FCF Yield
-0.54%-1.95%-2.57%68.08%-18.00%
Dividend Yield
0.02%0.05%1.24%1.09%4.06%-
Payout Ratio
-45.73%0.38%1.65%--
Buyback Yield / Dilution
-68.39%--551.03%-7.38%--0.02%
Total Shareholder Return
-68.36%0.05%-549.78%-6.29%4.06%-0.02%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.